Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment

Livin may serve as a promising marker to identify the relapse risk in bladder cancer, and targeting Livin could offer a therapeutic benefit in apoptosis-inducing treatment.